Indication
Macular Telangiectasia
1 clinical trial
2 products
Clinical trial
Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1Status: Recruiting, Estimated PCD: 2025-01-01
Product
AfliberceptProduct
SHAM